NodThera

NodThera is a biotechnology company dedicated to developing novel, effective, and selective NLRP3 inflammasome inhibitors for the treatment of diseases caused by chronic inflammation. Led by an experienced management team, NodThera will leverage new insights into inflammasome biology and chemistry to build a highly differentiated platform.